Epidemiologic modeling to evaluate prevention of mother-infant HIV transmission in Ontario

Journal of Acquired Immune Deficiency Syndromes

Volumn 34, Issue 2, 2003, Pages 221-230

  Remis, Robert S ^a   King, Susan M ^b   Vernich, Lee ^a   Major, Carol ^c   Whittingham, Elaine ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c ONTARIO MINISTRY OF HEALTH AND LONG TERM CARE   (Canada)

Author keywords

HIV; Ontario; Perinatal; Testing; Transmission

Indexed keywords

ANTIRETROVIRUS AGENT;

ABORTION; ACQUIRED IMMUNE DEFICIENCY SYNDROME; AGE; ARTICLE; CANADA; CHEMOPROPHYLAXIS; CONCEPTION; FEMALE; HEALTH CARE QUALITY; HEALTH PROGRAM; HEALTH SURVEY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INFANT; INFECTION PREVENTION; INFECTION RATE; MAJOR CLINICAL STUDY; MOTHER; PREGNANCY; PRENATAL SCREENING; PRIORITY JOURNAL; SCREENING TEST; VIRUS IDENTIFICATION; VIRUS TRANSMISSION;

ANTI-HIV AGENTS; DISEASE TRANSMISSION, VERTICAL; FEMALE; HIV INFECTIONS; HUMANS; INCIDENCE; MODELS, BIOLOGICAL; ONTARIO; PREGNANCY; TIME FACTORS;

EID: 0141958202     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126334-200310010-00013     Document Type: Article

References (40)

1. Coates RA, Frank JW, Arshinoff R, et al. The Ontario HIV seroprevalence study of childbearing women: results from the first year of testing. Clin Invest Med. 1992;15:1-7.
2. Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med. 1994;331:1173-1180.
3. Ioannidis JP, Abrams EJ, Ammann A, et al. Perinatal transmission of human immunodeficiency virus type 1 by pregnant women with RNA virus loads <1000 copies/ml. J Infect Dis. 2001;183:539-545.
4. Remis RS, King SM, Vernich L, et al. Preventing HIV transmission from mothers to infants in Ontario 1994 to 1996: a missed opportunity. Paper presented at: 12th International Conference on AIDS; 1998; Geneva, Switzerland. Abstract 23288.
5. Remis RS, Major C, Wallace E, et al. Report on HIV/AIDS in Ontario 2001. Toronto, Ontario: Ontario Ministry of Health and Long-Term Care; 2002.
6. Remis RS, Major C, Fearon M, et al. Enhancing HIV diagnostic data for surveillance of HIV infection: use of the detuned assay. Paper presented at: 13th International Conference on AIDS; 2000; Durban, South Africa. Abstract MoPeC2340.
7. Remis RS, Major C, Swantee C, et al. Trends in HIV incidence in Ontario based on the detuned assay of HIV-positive tests: an update. 10th Annual Conference of the Canadian Association for HIV/AIDS Research, Toronto, Ontario, Canada, May-June 2001. Abstract 313. Can J Infect Dis. 2001;12(suppl B):57B.
8. Peckham C, Gibb D. Mother-to-child transmission of the human immunodeficiency virus. N Engl J Med. 1995;333:298-302.
9. Stephenson JM, Griffioen A. The effect of HIV diagnosis on reproductive experience. Study Group for the Medical Research Council Collaborative Study of Women with HIV. AIDS. 1996;10:1683-1687.
10. Hankins C, Tran T, Lapointe N. Sexual behavior and pregnancy outcome in HIV-infected women. Canadian Women's HIV Study Group. J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18:479-487.
11. van Benthem BH, de Vincenzi I, Delmas MC, et al. Pregnancies before and after HIV diagnosis in a European cohort of HIV-infected women. European Study on the Natural History of HIV Infection in Women. AIDS. 2000;14:2171-2178.
12. Thackway SV, Furner V, Mijch A, et al. Fertility and reproductive choice in women with HIV-1 infection. AIDS. 1997;11:663-667.
13. Ross A, Morgan D, Lubega R, et al. Reduced fertility associated with HIV: the contribution of pre-existing subfertility. AIDS. 1999;13:2133-2141.
14. De Vincenzi I, Jadand C, Couturier E, et al. Pregnancy and contraception in a French cohort of HIV-infected women. SEROCO Study Group. AIDS. 1997;11:333-338.
15. Fearon M, Remis RS, Major C, et al. Uptake of HIV testing among pregnant women in Ontario: results of the HIV seroprevalence study to June 2001. Paper presented at: 14th International Conference on AIDS; 2002; Barcelona, Spain. Abstract WePeC6162.
16. Barnhart HX, Caldwell MB, Thomas P, et al. Natural history of human immunodeficiency virus disease in perinatally infected children: an analysis from the Pediatric Spectrum of Disease Project. Pediatrics. 1996;97: 710-716.
17. Bamji M, Thea D, Weedon J, et al. Prospective study of human immunodeficiency virus 1-related disease among 512 infants born to infected women in New York City. Pediatr Infect Dis J. 1996;15:891-898.
18. Scott GB, Hutto C, Makuch RW, et al. Survival in children with perinatally acquired human immunodeficiency virus type 1 infection. N Engl J Med. 1989;321:1791-1796.
19. Blanche S, Newell ML, Mayaux MJ, et al. Morbidity and mortality in European children vertically infected by HIV-1. J Acquir Immune Defic Syndr Hum Retrovirol. 1997;14:442-450.
20. King SM and the CPAR Group. Perinatal HIV infection in Ontario. 6th Annual Canadian Conference on HIV/AIDS Research, Ottawa, Canada, May 1997 (abstract 263). Can J Infect Dis. 1997;9(suppl A).
21. Boucher M, Samson J, Fauvel M, et al. Impact of ZDV treatment during pregnancy on mother-to-child HIV transmission in a clinical setting. 6th Annual Canadian Conference on HIV/AIDS Research, Ottawa, Canada, May 1997 (abstract 268). Can J Infect Dis. 1997;9(suppl A).
22. Forbes J, Burdge DR, Money D. Pregnancy outcome in HIV-infected women in British Columbia: the impact of antiretroviral therapy on maternal-infant HIV transmission. 6th Annual Canadian Conference on HIV/AIDS Research, Ottawa, Canada, May 1997 (abstract 235). Can J Infect Dis. 1997;9(suppl A).
23. Bitnun A, King SM, Arneson C, et al. Failure to prevent perinatal HIV infection. Can Med Assoc J. 2002;166:904-905.
24. Gorsky RD, Farnham PG, Straus WL, et al. Preventing perinatal transmission of HIV: costs and effectiveness of a recommended intervention. Public Health Rep. 1996;111:335-341.
25. Havens PL, Cuene BE, Holtgrave DR. Lifetime costs for children with human immunodeficiency virus infection. Pediatr Infect Dis J. 1997; 16: 607-610.
26. Postma MJ, Beck EJ, Sprenger HG, et al. The economic profile of antenatal HIV testing: pharmaceutical and methodological considerations. AIDS. 2003;17:755-757.
27. Guenter D, Carroll J, Kaczorowski J, et al. Prenatal HIV testing in Ontario. Can J Public Health. 2003;94:93-97.
28. Patrick DM, Money DM, Forbes J, et al. Routine prenatal screening for HIV in a low-prevalence setting. Can Med Assoc J. 1998;159:942-947.
29. Bureau of HIV/AIDS. STD and TB Update series. Perinatal transmission of HIV. HIV/AIDS Epi Update [webpage], Ottawa, Canada May 2002. Available from: (http://www.hc-sc.gc.ca/pphb-dgspsp/publicat/epiu-aepi/hiv-vih/peri_e.html). Accessed February 22, 2003.
30. Jayaraman GC, Preiksaitis JK, Larke B. Mandatory reporting of HIV infection and opt-out prenatal screening for HIV infection: Effect on testing rates. Can Med Assoc J. 2003;168:679-682.
31. Boucher M, Samson J, Lapointe N. HIV screening among pregnant women in the province of Quebec: success and failure. 11th Annual Conference of the Canadian Association for HIV/AIDS Research, Winnipeg, Canada, April 2002 (abstract223). Can J Infect Dis. 2002;13 (suppl A):30A
32. Centers for Disease Control and Prevention. HIV testing among pregnant women: United States and Canada, 1998-2001. Morb Mortal Wkly Rep. 2002;51:1013-1016.
33. Cliffe S, Tookey PA, Nicoll A. Antenatal detection of HIV: national surveillance and unlinked anonymous survey. BMJ. 2001;323:376-377.
34. Remis RS, Guenter D, King S. Testing pregnant women in Canada for HIV: how are we doing? Can Fam Physician. 2001;47:2193-2195.
35. Walmsley S. Opt-in or opt out: what is optimal for prenatal screening for HIV infection? Can Med Assoc J. 2003;168:707-708.
36. Stringer EM, Stringer JS, Cliver SP, et al. Evaluation of a new testing policy for human immunodeficiency virus to improve screening rates. Obstet Gynecol. 2001;98:1104-1108.
37. Centers for Disease Control and Prevention. Revised guidelines for HIV counselling, testing, and referral and revised recommendations for HIV screening of pregnant women. Morb Mortal Wkly Rep 2001;50(No RR-19):59-85.
38. Phillips KA, Bayer R, Chen JL. New Centers for Disease Control and Prevention's guidelines on HIV counseling and testing for the general population and pregnant women. J Acquir Immune Defic Syndr. 2003;32: 182-191.
39. Fowler MG, Simonds RJ, Roongpisuthipong A. Update on perinatal HIV transmission. Pediatr Clin North Am. 2000;47:21-38.
40. Bulterys M, Fowler MG. Prevention of HIV infection in children. Pediatr Clin North Am. 2000;47:241-260.